Wednesday, March 23 – Thursday, March 24, 2011 Washington, DC Metro Area The Liaison Capitol Hill 415 New Jersey Avenue, NW Washington, DC 20001 Molecular Diagnostics And the Changing Landscape is an […]
Molecular Diagnostics a Natural Fit for Breast Cancer
The growing global incidence of breast cancer has led to an increased demand for molecular diagnostics tests that aid in diagnosing breast cancer.
Luminex Corp. Launches Its First Pharmacogenomics Test for Personalized Medicine
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
GE Healthcare to Acquire Diagnostics Company Clarient
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
